Beyond its increased expression, the proteasome complex in melanoma cells may also be overactive because of the overexpressed PSME2 gene and the proteasome activator complex subunit 2 (aka PA28B), thus contributing, in turn, to the increased antigen presentation by the MHC class I pathway discussed above (see Figure 2). The gene discussed is PSME2; the disease is melanoma.